NYSE / NASDAQ · SEC EDGAR

Equity research

Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.

Research preview · Quarterly financial statements · No price quotes · Not financial advice

2–3 year stock research →

7626Listed tickers in the SEC universe 4350Issuers with current reporting periods 1430Issuers with both EPS and ROE metrics 2026-11-06Fundamentals evaluated as of

Example screens

Reset filters

All selected filters are combined. Paste up to 100 tickers to intersect your own list with the results. A missing metric does not pass a numeric filter.

4350 companies match

Showing 1751–1800 of 4350 · page 36/87

Per page 2550100
CompanyCombined rankEPS accelerationRevenue growthROENet margin Reporting period
BARKBark, Inc.NYSE — — -23.4% -41.0% -8.4% 2026-06-30Filed 2026-08-06
BATLBATTALION OIL CORPNYSE — — 12.7% -19.6% -24.6% 2026-06-30Filed 2026-08-12
BATRAAtlanta Braves Holdings, Inc.NASDAQ — — -2.3% -12.5% -8.6% 2026-06-30Filed 2026-08-05
BAVABitwise Avalanche ETFNYSE — — — — — 2026-06-30Filed 2026-08-12
BAXBAXTER INTERNATIONAL INCNYSE — — 5.0% -11.1% -6.2% 2026-09-30Filed 2026-10-29
BBBLACKBERRY LtdNYSE — — 26.0% 10.2% 13.1% 2026-08-31Filed 2026-09-24
BBAIBigBear.ai Holdings, Inc.NYSE — — 31.5% -26.4% -126.8% 2026-09-30Filed 2026-10-28
BBCPConcrete Pumping Holdings, Inc.NASDAQ — — 13.1% 3.9% 2.7% 2026-07-31Filed 2026-09-03
BBDCBarings BDC, Inc.NYSE — 0.0 pp — — — 2026-06-30Filed 2026-08-05
BBGIBEASLEY BROADCAST GROUP INCNASDAQ — — -16.7% -273.5% -55.7% 2026-06-30Filed 2026-08-14
BBIOBridgeBio Pharma, Inc.NASDAQ — — 192.6% — — 2026-09-30Filed 2026-10-29
BBLGBone Biologics CorpNASDAQ — — — -47.8% — 2026-09-30Filed 2026-10-26
BBNXBeta Bionics, Inc.NASDAQ — — 30.3% -20.7% -65.3% 2026-09-30Filed 2026-10-27
BBOTBridgeBio Oncology Therapeutics, Inc.NASDAQ — — — -56.4% — 2026-06-30Filed 2026-08-11
BBSIBARRETT BUSINESS SERVICES INCNASDAQ — — — 17.2% — 2026-06-30Filed 2026-08-06
BBWIBath & Body Works, Inc.NYSE — 9.7 pp -2.3% — 10.8% 2026-08-01Filed 2026-08-26
BCAXBicara Therapeutics Inc.NASDAQ — — — -39.5% — 2026-06-30Filed 2026-08-11
BCBPBCB BANCORP INCNASDAQ — — — -6.0% — 2026-06-30Filed 2026-08-10
BCCQBleichroeder Acquisition Corp. IIINASDAQ — — — — — 2026-06-30Filed 2026-08-14
BCDABioCardia, Inc.NASDAQ — — — -271.8% — 2026-06-30Filed 2026-08-12
BCGBinah Capital Group, Inc.NASDAQ — — 11.8% 20.0% 2.2% 2026-06-30Filed 2026-08-13
BCHTBirchtech Corp.NYSE — — 16.5% — — 2026-06-30Filed 2026-08-13
BCICBCP Investment CorpNASDAQ — — — -2.2% — 2026-06-30Filed 2026-08-06
BCRXBIOCRYST PHARMACEUTICALS INCNASDAQ — — — — — 2026-06-30Filed 2026-08-05
BCSSBain Capital GSS Investment Corp.NYSE — — — — — 2026-06-30Filed 2026-08-13
BCTXBriaCell Therapeutics Corp.NASDAQ — — — -224.3% — 2026-07-31Filed 2026-10-28
BCYCBICYCLE THERAPEUTICS PLCNASDAQ — — 190.2% -28.1% -169.8% 2026-09-30Filed 2026-10-29
BDCIBTC Development Corp.NASDAQ — — — — — 2026-06-30Filed 2026-08-10
BDNBRANDYWINE REALTY TRUSTNYSE — — 3.5% — — 2026-09-30Filed 2026-10-29
BDRYAmplify Commodity TrustNYSE — — — 175.5% — 2026-06-30Filed 2026-09-25
BDSXBIODESIX INCNASDAQ — — 34.2% -303.6% -27.0% 2026-06-30Filed 2026-08-05
BDTXBlack Diamond Therapeutics, Inc.NASDAQ — — — -44.3% — 2026-06-30Filed 2026-08-05
BEBloom Energy CorpNYSE — — 139.8% — — 2026-09-30Filed 2026-10-22
BEAGBold Eagle Acquisition Corp.NASDAQ — — — — — 2026-06-30Filed 2026-08-14
BEAMBeam Therapeutics Inc.NASDAQ — — -94.2% -8.0% -54.7% 2026-06-30Filed 2026-08-04
BEATHeartBeam, Inc.NASDAQ — — — -248.2% — 2026-06-30Filed 2026-08-13
BEBETGE Value Creative Solutions CorpNYSE — — — — — 2026-06-30Filed 2026-08-14
BEEMBeam GlobalNASDAQ — — 21.0% -84.6% -64.6% 2026-06-30Filed 2026-08-19
BEEPMobile Infrastructure CorpNASDAQ — — -1.1% -18.0% -67.2% 2026-06-30Filed 2026-08-11
BELFABEL FUSE INC /NJNASDAQ — — 25.2% — — 2026-06-30Filed 2026-08-04
BENFBeneficientNASDAQ — — — — — 2026-06-30Filed 2026-08-14
BESSBimergen Energy CorpNYSE — — — -16.4% — 2026-06-30Filed 2026-08-14
BETABETA Technologies, Inc.NYSE — — 145.7% -53.1% -1913.9% 2026-06-30Filed 2026-08-12
BETRBetter Home & Finance Holding CoNASDAQ — — — -310.8% — 2026-06-30Filed 2026-08-11
BF-ABROWN FORMAN CORPNYSE — — -1.4% 18.2% 18.4% 2026-07-31Filed 2026-09-02
BFLYButterfly Network, Inc.NYSE — — 51.7% -29.1% -43.6% 2026-09-30Filed 2026-10-29
BFRGBullFrog AI Holdings, Inc.NASDAQ — — 547.6% -85.8% — 2026-06-30Filed 2026-08-14
BFRIBiofrontera Inc.NASDAQ — — 32.9% -106.9% -13.8% 2026-06-30Filed 2026-08-13
BGDEBig Digital Energy, Inc.NASDAQ — — -35.5% -177.5% -80.7% 2026-06-30Filed 2026-08-14
BGLCBioNexus Gene Lab CorpNASDAQ — — -96.6% -33.1% -82.4% 2026-06-30Filed 2026-08-14

How the lists overlap

EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.

The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.

Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.

What this data covers

Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.

The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.

Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.

Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-11-05. Source: FRED / Federal Reserve.